Loading...
Autolus Therapeutics Community
NasdaqGS:AUTL Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 18 Fair Values set on narratives written by author
Community Investing Ideas
Robust Clinical Uptake Will Expand Advanced Cancer Therapy Adoption
Key Takeaways Accelerating adoption, regulatory progress, and expanded clinical indications position Autolus for increased market share and long-term revenue growth in advanced cancer therapies. Improved manufacturing efficiency and financial discipline strengthen margins, enabling investment in innovation and geographic expansion while supporting sustained profitability.Read more
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
US$9.62
85.8% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
127.89% p.a.
Profit Margin
16.06%
Future PE
57.45x
Share price in 2028
US$12.28